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Abstract
Background: There is growing evidence that male circumcision (MC) prevents heterosexual
acquisition of HIV by males in sub-Saharan Africa, the region of the world heavily affected by the
HIV pandemic. While there is growing support for wide-spread availability and accessibility of MC
in Africa, there is limited discussion about the prevalence of physical complications of male
circumcision on the continent.
Methods: A systematic literature search and review of articles in indexed journals and conference
abstracts was conducted to collect and analyze prevalence of complications of MC in Anglophone
sub-Saharan Africa. Information extracted included: indications for MC, complications reported,
age of patients and category of circumcisers.
Results: There were 8 articles and 2 abstracts that were suitable for the analysis. The studies were
not strictly comparable as some reported on a wide range of complications while others reported
just a limited list of possible complications. Prevalence of reported complications of MC ranged
from 0% to 50.1%. Excluding the study with 50.1%, which was on a series of haemophilia patients,
the next highest prevalence of complications was 24.1%. Most of the complications were minor.
There was no firm evidence to suggest that MCs performed by physician surgeons were associated
with lower prevalence of complications when compared with non-physician health professionals.
Conclusion:  The available data are inadequate to obtain a reasonable assessment of the
prevalence of complications of MC in sub-Saharan Africa. Some of the available studies however
report potentially significant prevalence of complications, though of minor clinical significance. This
should be considered as public health policy makers consider whether to scale-up MC as an HIV
preventative measure. Decision for the scale-up will depend on a careful cost-benefit assessment
of which physical complications are certainly an important aspect. There is need for standardized
reporting of complications of male circumcision.
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Background
The HIV pandemic is among the most critical public
health challenges facing the African continent. Observa-
tional studies and three randomized controlled trials
(RCTs) have reported that male circumcision can prevent
HIV acquisition heterosexually by men [1-3]. Williams et
al [4] have conducted mathematical models showing that
wide-scale implementation of MC has the potential of
reducing 2.0 million (1.1–3.8 million) new HIV infec-
tions in the first ten years of implementation in sub-Saha-
ran Africa.
Several studies have reported on the acceptability of male
circumcision for the prevention of HIV in sub-Saharan
Africa [5-7]. In a review, Westercamp and Bailey report
that there is sufficient research evidence to suggest that
male circumcision is acceptable in sub-Saharan Africa for
the prevention of HIV transmission [8]. However, Mills
and Siegfried have suggested a "cautious optimism"
approach towards male circumcision [9]. There is on-
going debate as to whether male circumcision should be
routinely performed for the purpose of preventing hetero-
sexual transmission of HIV in sub-Saharan Africa [10-15].
While the literature has focused on the role of MC in the
prevention of transmission of HIV in sub-Saharan Africa,
we argue that there has not been commensurate interest in
the estimation of safety and complications potentially
associated with any scale-up in MC in Africa. In conduct-
ing this review, we were motivated to find out the availa-
ble evidence regarding the reported prevalence of
complications of MC in Africa. We therefore conducted a
review of the published literature to attempt to answer the
question: What has been the reported prevalence of com-
plications of MC in sub-Saharan Africa? A secondary ques-
tion is: Who is conducting MC in Africa?
Methods
Search strategy and selection criteria
We searched for all reports in peer-reviewed journals that
reported on complications of male circumcision in sub-
Saharan Africa and abstracts from the International Con-
ference on AIDS (2004 and 2006). Journal databases
searched included: African Journals Online (AJOL),
MEDLINE, OVID, Google Scholar and Web of Science.
The search period was limited to 1980 and August 2006.
We used the key word: "circumcision". Studies were
included for analysis if they reported on any series of
patients in Anglophone Africa on whom male circumci-
sion had been conducted and complications reported.
ASM, RM and JII participated in the data collection. Data
abstracted included: author details, location of study,
number of patients circumcised in the reported series,
ages of patients, inclusion criteria for procedure, preva-
lence of complications, nature of complications reported,
period of follow-up for reporting of complications, indi-
cations for circumcision and who performed the circum-
cisions. Only studies published in English were included,
irrespective of study design. Our method used applicable
recommendations from the Meta-Analysis of Observa-
tional Studies in Epidemiology (MOOSE) guidelines as
reported by Stroup et al [16].
Results
Clinical characteristics of cases
Eight articles and two conference abstracts were consid-
ered suitable for the review. The papers reported on stud-
ies conducted in Kenya, Nigeria, South Africa and
Tanzania. Table 1 reports on indications reported for MC,
exclusion criteria of cases, length of period of follow-up
and the range of complications reported, which included
zero reporting. Zero reporting means type of complication
was reported as having never occurred.
Studies included randomized controlled clinical trials and
reports of routine clinical work. The inclusion and exclu-
sion criteria in the series of cases were diverse with the
RCTs reporting stringent inclusion criteria of cases while
the routine series of patients were generally less restrictive.
The lists of complications reported in studies were differ-
ent. The period of follow-up to document complications
were variable ranging from just immediate post-operative
up to a year. 4 of the 10 studies did not report follow-up
time.
Complications of male circumcision
Table 2 reports on the total number of cases in a series
group, age of patients, categories of circumciser and prev-
alence of complications reported. The prevalence of com-
plication reported ranged from 0% to 50.1% in a series of
hemophiliacs. Different professional categories per-
formed circumcision. There were equivocal reports on the
comparison of complications between circumcisions per-
formed by nurses versus those performed by physicians.
Association between category of circumciser and 
complications
Several studies reported high prevalence of complications
when circumcision was conducted by untrained person-
nel. Osuigwe et al [23] reported that midwives were asso-
ciated with 30.6% complications compared to physicians
at 14.5%. However, physicians at a university teaching
hospital were associated with fewer complications com-
pared to private and mission hospital physicians. The
series of cases by Magoha [26] and Manji [25] were oper-
ated on by one physician in each case and no comparisons
could be made about the skill of the circumciser. Auvert et
al study [20] used general physicians for all their subjects.
Okeke et al [19] reported more complications with nursesB
M
C
 
U
r
o
l
o
g
y
 
2
0
0
7
,
 
7
:
4
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
1
-
2
4
9
0
/
7
/
4
P
a
g
e
 
3
 
o
f
 
6
(
p
a
g
e
 
n
u
m
b
e
r
 
n
o
t
 
f
o
r
 
c
i
t
a
t
i
o
n
 
p
u
r
p
o
s
e
s
)
Table 1: Socio-clinical characteristics of male circumcision cases included in the review
Author(s) Reasons for circumcision Exclusion Criteria Period of follow-up Complications reported
Bailey et al [17] Randomized controlled trial HIV infection 8 days bleeding, infection
Kiwanuka et al [18] Randomized controlled trial Not reported 6 weeks Not reported
Okeke at al [19] Non medical reasons Not reported Not reported redundant foreskin, excessive skin, skin bridges, amputation 
of glans, buried penis, hemorrhage
Auvert et al [20] Randomized controlled trial Any contraindication to MC and HIV infection 1 month pain, excessive bleeding, infection, damage to penis, 
anesthetic complications, excessive skin removal, 
insufficient skin removal, delayed healing, cosmetic 
concerns, problems with urination
Krieger et al [21] Randomized controlled trial Any medical contraindications to MC e.g. 
paraphimosis, Significant phimosis, recurrent 
balanitis, history of bleeding, keloid formation
30 days infections, bleeding, delayed healing, disrupted wound, 
swelling, anesthetic, erectile dysfunction
Okafor et al [22] Feasibility study of MC Lack of parental consent, preterm birth, congenital 
anomalies, low APGAR score, history of neonatal 
jaundice in a sibling, jaundice at birth
1 year None
Osuigwe et al [23] Parental request None reported 6 weeks bleeding, incomplete circumcision, meatal stenosis, urethral 
laceration
Shittu and Shokunbi [24] socio-cultural None not reported bleeding
Manji [25] socio-cultural, religious none not specified infection, bleeding, haematoma
Magoha [26] cultural, religious, phimosis, 
paraphimosis, urinary infection, acute 
infection, hygienic reasons, enhanced 
sexual sensation, preputial cyst
None reported Not reported wound infection, hemorrhage, retention of urine, penile 
edema, haematoma, scrotal laceration, wound dehiscence, 
glans injury, meatal stenosisBMC Urology 2007, 7:4 http://www.biomedcentral.com/1471-2490/7/4
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compared to physicians. However, the difference was not
statistically significant.
Discussion
There is limited published literature on the complications
of male circumcision in sub-Saharan Africa. The available
evidence regarding the prevalence of complications in
male circumcision is conflicting, with some studies
reporting significantly high complications prevalence and
at least one study reporting no complications. It is plausi-
ble to consider that a study that may not have reported a
single complication may indeed have none to report or
that complications may have been consider so minor as to
be 'worth' reporting. In case of complications that may be
experienced at home and there are significant barriers to
access medical care, it is conceivable to expect that many
patients will not present to health facilities for care follow-
ing minor to moderate complications. Another explana-
tion for no report of complications may be that the
patients may have presented for management of compli-
cations at a different facility from where they obtained cir-
cumcision.
In virtually all the studies reviewed, the majority of com-
plications reported were of minor clinical consequence.
The exception was the study by Shittu and Shokunbi [24]
which reported on a special group of patients i.e. hemo-
philiacs, with extremely high risk of bleeding from mini-
mal trauma. The interpretation of prevalence of
complications in this study must be made within these
special circumstances. Other than the report of bleeding,
no other complication was reported. It is unlikely though
that bleeding was the only complication experienced;
rather it would seem that this was the main focus of the
study.
Reports on complications of male circumcision also differ
in so far as the time after the circumcision that complica-
tions were reported i.e. early versus late complications.
Yegane et al [27] for instance have reported on possible
late complications of MC which include granuloma for-
mation, penile rotation and secondary chordee [27]. In
some of the studies that were reviewed in our study like
that of Bailey et al [17] where patients were followed up
for complications for 8 days, long term complications
such as keloid formation may have been missed. Bailey et
al's randomized controlled study however was of much
longer duration and the assessment of long term compli-
cations was possible, but not reported. In general, most of
the studies we reviewed reported on bleeding and infec-
tions only. Auvert's et al study however had reported an
extensive list of possible complications and included zero
reporting. Of the complications reported by Auvert et al,
13 (31.7%) reported pain, excessive bleeding (15%),
infection (5%), damage to penis (5%), 1 anesthetic com-
plications and 9 complaints of problems with appearance.
The prevalence of complications of MC in North America
has been reported in the range of 0.2% to 0.5% [28].
However, the true prevalence of complications is not
known as ways of ascertaining these will always underes-
timate the true prevalence [28]. Ben Chaim et al [29] have
Table 2: Prevalence of Complications of Male Circumcision Reported From sub-Saharan Africa
Author Location Total number 
of patients
Ages of 
Patients
Circumcisers Number of 
complications
Prevalence of 
Complications
Bailey et al [17] Kisumu, Kenya 1334 18–24 yrs Not indicated 23 1.7%
Kiwanuka et [18] Rakai, Uganda 136 15–49 years Not indicated 5 3.7%
Okeke et al [19] Ibadan, Nigeria 322 < 1 yr Nurses, physicians and 
traditional circumcisers
65 20.2%
Auvert et al [20] Orange Farm, 
South Africa
1568 18–24 yrs Generalist physicians 60 3.8%
Krieger et al [21] Kisumu, Kenya 479 18–24 yrs Physicians and clinical 
officers
17 3.5%
Okafor et al [22] Nigeria 102 < 1 yr Physicians 0 0
Osuigwe et al [23] Nigeria 138 neonates Physicians and nurses 33 24.1%
Shittu and Shokunbi 
[24]]
Ibadan, Nigeria 70 hemophiliacs birth to 35 yrs Nurses, physicians, 
community health 
workers and traditional 
circumcisers
35 50.1%
Manji [25]] Tanzania 386 < 1 yr Pediatricians 11 2.8%
Magoha [26]] Lagos, Nigeria and 
Nairobi, Kenya
249 birth to 54 years Specialist Surgeon 
physicians
28 11.2%BMC Urology 2007, 7:4 http://www.biomedcentral.com/1471-2490/7/4
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reported on series of 19,478 male infant circumcision
conducted in Israel, of which only 66 (1.3%) recorded
complications. This study reported fewer complications
than most of the studies we reviewed but prevalence was
higher than the single study that reported no complica-
tions.
The study by Okafor et al [22] which reported no compli-
cations, had potentially 119 neonates but 17 were
excluded for a variety of reasons. This could suggest that
proper selected of MC candidates will be necessary to
minimize complications. However, such conclusion may
not be justified in the absence of data on the criteria for
exclusion i.e. the selection may have or may have not
influenced the prevalence of complications.
There are always concerns about the safety of MC in sub-
Saharan African health systems. Mattson et al reported on
the feasibility of performing MC in health facilities in
Kenya. The lack of basic instruments and inadequate sup-
plies were identified as crucial limitations in facilitating
provision of safe MC in that country [30]. Ahmed [31]
studied circumcision practices in Anjouan, Comoros and
reported that circumcisions by trained lay people were as
safe as those carried out by physicians in hospitals. Train-
ing and supervision was emphasized in this series.
The special cases of complications in haemophiliacs
deserve special mention. It has been reported that the use
of fibrin glue or the "diathermic knife" may prevent bleed-
ing and transfusion with blood factors [32,33]. These sup-
plies will need to be considered if MC is to be scaled-up,
but will increase the cost of the procedure.
It is reasonable to expect that prevalence of complications
from MC in Africa is likely to be higher than in countries
with well-resourced health systems. While that expecta-
tion is reasonable and perhaps will be realized, a recent
publication by Archibald et al is also informative [34].
Archibald et al compared contamination of blood culture
specimens at Duke Medical Center (Durham, North Caro-
lina, United States), Kamuzu Central Hospital (Malawi)
and Muhimbili National Hospital (Tanzania). Contami-
nation of specimens at both African centers was less than
2% while it was 28% at Duke Medical Center. The expec-
tation that developing country health systems will always
perform poorly when compared to developed nation
health systems may therefore not be justified.
Conclusion
The literature on prevalence of complications following
male circumcision in sub-Saharan Africa is limited. Most
of the complications reported have been of minor clinical
consequence. Reporting practices also have been varied
such that comparisons among studies with regard to age
of patients, indications for circumcision, duration of fol-
low-up of complications and categories of circumcisers
are difficult. There is need to develop and encourage
standardized reporting of complications of male circum-
cisions. We believe that the finding that there is not
enough data to suggest that MC is associated with more
than the 'average' risk in Africa is important as public pol-
icy discussions gain momentum as whether to scale-up
provision and accessibility of the procedure to prevent
HIV transmission.
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